Inventor · disambiguated record
Timothy M. Block
Also filed as: BLOCK TIMOTHY · BLOCK TIMOTHY M · Block Timothy Michael
36 granted patents·33 pending applications·346 citations·filing 1992–2025
97Inventor score
Top patents by PatentIndex Score
69 records- 0195US9623071B2Modulation of hepatitis B virus CCCDNA transcriptionUNIV DREXEL·Filed 2013·Granted Apr 18, 2017·32 cites·15 claims
- 0292US7776550B2Diagnosis of liver pathology through assessment of protein glycosylationPHILADELPHIA HEALTH & EDUCATIO·Filed 2006·Granted Aug 17, 2010·18 cites·5 claims
- 0391US8609668B2Substituted triazolo[1,5-A]pyrimidines as antiviral agentsCUCONATI ANDREA·Filed 2007·Granted Dec 17, 2013·39 cites·2 claims
- 0490US8921381B2Inhibitors of secretion of hepatitis B virus antigensXU XIAODONG·Filed 2011·Granted Dec 30, 2014·8 cites·10 claims
- 0590US8183000B2Diagnosis of liver pathology through assesment of protein glycosylationBLOCK TIMOTHY M·Filed 2010·Granted May 22, 2012·9 cites·9 claims
- 0688US10045961B2Use of sting agonists to treat chronic hepatitis B virus infectionUNIV DREXEL·Filed 2017·Granted Aug 14, 2018·6 cites·23 claims
- 0788US8097728B2Iminosugar compounds with antiflavirus activityGU BAOHUA·Filed 2008·Granted Jan 17, 2012·41 cites·20 claims
- 0887US7612093B2Compositions of treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds in combination therapyUNITED THERAPEUTICS CORP·Filed 2005·Granted Nov 3, 2009·3 cites·9 claims
- 0986US9642830B2Use of sting agonists to treat hepatitis B virus infectionUNIV DREXEL·Filed 2014·Granted May 9, 2017·7 cites·27 claims
- 1086US9399619B2Sulfamoylbenzamide derivatives as antiviral agents against HBV infectionGUO JU-TAO·Filed 2012·Granted Jul 26, 2016·11 cites·8 claims
- 1182US9089515B2Long chain N-alkyl compounds and oxa-derivatives thereofZITZMANN NICOLE·Filed 2011·Granted Jul 28, 2015·9 cites·23 claims
- 1281US9938236B2Antiviral agents against HBV infectionUNIV DREXEL·Filed 2013·Granted Apr 10, 2018·5 cites·19 claims
- 1381US7816560B1Long chain n-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2000·Granted Oct 19, 2010·10 cites·4 claims
- 1479US9040488B2Imino sugar derivatives demonstrate potent antiviral activity and reduced toxicityBLOCK TIMOTHY M·Filed 2009·Granted May 26, 2015·1 cites·6 claims
- 1578US11408888B2Early detection of hepatocellular carcinomaUNIV DREXEL·Filed 2017·Granted Aug 9, 2022·1 cites·16 claims
- 1677US6689759B1Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapySEARLE & CO·Filed 1998·Granted Feb 10, 2004·46 cites·55 claims
- 1776US6809083B1Use of N-substituted-1, 5-dideoxy-1, 5-imino-D-glucitol compounds for treating hepatitis virus infectionsFiled 1999·Granted Oct 26, 2004·31 cites·3 claims
- 1875US2023104136A1Early Detection Of Hepatocellular CarcinomaUNIV DREXEL·Filed 2022·Application pending·0 cites
- 1973US2021033627A1Diagnosis of Liver Pathology Through Assessment of Protein GlycosylationUNIV DREXEL·Filed 2020·Application pending·0 cites
- 2072US6465487B1Inhibition of membrane-associated viral replicationSYNERGY PHARMACEUTICALS INC·Filed 1998·Granted Oct 15, 2002·32 cites·38 claims
- 2172US2025164493A1Early Detection Of Hepatocellular CarcinomaUNIV DREXEL·Filed 2025·Application pending·0 cites
- 2272US2021070703A1Sulfamoylbenzamide derivatives as antiviral agents against hbv infectionUNIV DREXEL·Filed 2020·Application pending·0 cites
- 2369US2021041458A1Lectin Assay For Assessing Glycoforms As An Early Marker In DiseaseBARUCH S BLUMBERG INST·Filed 2020·Application pending·0 cites
- 2466US9533990B2Inhibitors of secretion of hepatitis B virus antigensUNIV DREXEL·Filed 2014·Granted Jan 3, 2017·0 cites·13 claims
- 2565US2019337891A1Sulfamoylbenzamide derivatives as antiviral agents against hbv infectionUNIV DREXEL·Filed 2019·Application pending·0 cites
- 2664US10823740B2Diagnosis of liver pathology through assessment of protein glycosylationUNIV DREXEL·Filed 2016·Granted Nov 3, 2020·0 cites·8 claims
- 2764US9110078B2Diagnosis of liver pathology through assessment of anti-gal IgG glycosylationBLOCK TIMOTHY M·Filed 2008·Granted Aug 18, 2015·1 cites·11 claims
- 2860US2017320818A1Sulfamoylbenzamide derivatives as antiviral agents against hbv infectionUNIV DREXEL·Filed 2017·Application pending·0 cites
- 2959US9758477B2Sulfamoylbenzamide derivatives as antiviral agents against HBV infectionUNIV DREXEL·Filed 2015·Granted Sep 12, 2017·0 cites·2 claims
- 3059US2016327571A1Lectin Assay For Assessing Glycoforms As An Early Marker In DiseaseBARUCH S BLUMBERG INST·Filed 2016·Application pending·0 cites
- 3158US9168260B2Benzodiazepine compounds with anti-flavivirus activityBARUCH S BLUMBERG INST·Filed 2013·Granted Oct 27, 2015·0 cites·1 claims
- 3257US10180436B2Diagnosis of liver pathology through assessment of anti-gal IgG glycosylationUNIV DREXEL·Filed 2015·Granted Jan 15, 2019·0 cites·17 claims
- 3357US10143720B2Modulation of hepatitis B virus cccDNA transcriptionUNIV DREXEL·Filed 2017·Granted Dec 4, 2018·0 cites·5 claims
- 3457US9126937B2Alkylated imino sugars exhibiting glucosidase inhibition and their method of useBARUCH S BLUMBERG INST·Filed 2013·Granted Sep 8, 2015·0 cites·7 claims
- 3557US8193328B2Identification of modulators of serine protease inhibitor Kazal and their use as anti-cancer and anti-viral agentsLU XUANYONG·Filed 2006·Granted Jun 5, 2012·1 cites·2 claims
- 3657US2012196277A1Diagnosis of liver pathology through assessment of protein glycosylationBLOCK TIMOTHY M·Filed 2012·Application pending·0 cites
- 3757US2017136120A1Induction of immune responseUNIV DREXEL·Filed 2017·Application pending·0 cites
- 3856US6355248B1Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agentUNIV JEFFERSON·Filed 1999·Granted Mar 12, 2002·19 cites·27 claims
- 3956US2018369323A1Modulation of hepatitis b virus cccdna transcriptionUNIV DREXEL·Filed 2018·Application pending·0 cites
- 4055US2010137365A1Long chain N-alkyl compounds and oxa-derivatives thereofUNIV JEFFERSON·Filed 2010·Application pending·0 cites
- 4155US2025296929A1Novel hepatoselective polyadenylating polymerases inhibitors and their method of useBARUCH S BLUMBERG INST·Filed 2022·Application pending·0 cites
- 4255US2015198610A9Lectin Assay for Assessing Glycoforms as an Early Marker in DiseaseROMANO PATRICK ROBERT·Filed 2012·Application pending·0 cites
- 4355US2018311206A1Use of sting agonists to treat chronic hepatitis b virus infectionUNIV DREXEL·Filed 2018·Application pending·0 cites
- 4454US2013142827A1Induction of immune responseBLOCK TIMOTHY M·Filed 2011·Application pending·0 cites
- 4554US2005267153A1Use of N-substituted-1,5-dideoxy-1,5-imino-D-glucitol compounds for treating hepatitis virus infectionsMUELLER RICHARD A·Filed 2004·Application pending·0 cites
- 4653US10082512B2Diagnosis of liver pathology through assessment of protein glycosylationBLOCK TIMOTHY M·Filed 2006·Granted Sep 25, 2018·0 cites·10 claims
- 4752US2010285469A1Method of tumor screeningPHILADELPHIA HEALTH & EDUCATIO·Filed 2008·Application pending·0 cites
- 4851US10376502B2Alkylated imino sugars exhibiting glucosidase inhibition and their method of useBARUCH S BLUMBERG INST·Filed 2015·Granted Aug 13, 2019·0 cites·5 claims
- 4951US6037351AMethod of inhibiting hepatitis B virusSEARLE & CO·Filed 1994·Granted Mar 14, 2000·8 cites·3 claims
- 5051US2016051665A1Induction of immune responseUNIV DREXEL·Filed 2015·Application pending·0 cites
Showing the top 50 of 69 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Timothy M. Block files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →